Abstract
Background: Distinguishing ICU patients with candidaemia can help with the precise prescription of antifungal drugs to create personalized guidelines. Previous prediction models of candidaemia have primarily used traditional logistic models and had some limitations. In this study, we developed a machine learning algorithm trained to predict candidaemia in patients with new-onset systemic inflammatory response syndrome (SIRS).Methods: This retrospective, observational study used clinical information collected between January 2013 and December 2017 from three hospitals. The ICU patient data were used to train 4 machine learning algorithms–XGBoost, Support Vector Machine (SVM), Random Forest (RF), ExtraTrees (ET)–and a logistic regression (LR) model to predict patients with candidaemia.Results: Of the 8,002 cases of new-onset SIRS (in 7,932 patients) included in the analysis, 137 new-onset SIRS cases (in 137 patients) were blood culture positive for candidaemia. Risk factors, such as fungal colonization, diabetes, acute kidney injury, the total number of parenteral nutrition days and renal replacement therapy, were important predictors of candidaemia. The XGBoost machine learning model outperformed the other models in distinguishing patients with candidaemia [XGBoost vs. SVM vs. RF vs. ET vs. LR; area under the curve (AUC): 0.92 vs. 0.86 vs. 0.91 vs. 0.90 vs. 0.52, respectively]. The XGBoost model had a sensitivity of 84%, specificity of 89% and negative predictive value of 99.6% at the best cut-off value.Conclusions: Machine learning algorithms can potentially predict candidaemia in the ICU and have better efficiency than previous models. These prediction models can be used to guide antifungal treatment for ICU patients when SIRS occurs.
Highlights
Invasive fungal diseases (IFDs) are life-threatening infections, and their morbidity and mortality have increased in recent decades [1, 2]
45% of Candida bloodstream infections occur in critical care units and have become a leading cause of death among ICU patients [7]
3,1070 new-onset systemic inflammatory response syndrome (SIRS) incidents for 28,143 patients were included in this study
Summary
Invasive fungal diseases (IFDs) are life-threatening infections, and their morbidity and mortality have increased in recent decades [1, 2]. 45% of Candida bloodstream infections occur in critical care units and have become a leading cause of death among ICU patients [7]. Previous studies have proven that early optimal antifungal treatment can decrease patient mortality [8,9,10]. A definitive diagnosis of candidaemia mainly relies on blood culture [11,12,13], which takes time and can cause a delay in timely treatment of patients. Recognition is very difficult, and the indiscriminate use of antifungal agents can cause drug resistance and increase the patient’s economic burden. Distinguishing ICU patients with candidaemia can help with the precise prescription of antifungal drugs to create personalized guidelines. We developed a machine learning algorithm trained to predict candidaemia in patients with new-onset systemic inflammatory response syndrome (SIRS)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.